// App-Quantinova.ai

P-165 : The feasibility of tumor recurrence detection in liver post-transplantation for patients with hepatocellular carcinoma via personalized, tumor-informed ctDNA testing

Researchers

Presenter

  • M. Abdelrahim

Principal Investigators

  • A. Esmail

  • A. Saharia

  • A. He

  • H. Dhani

  • V. Aushev

  • A. Jurdi

  • J. Starr

  • P. Gauthier

Medical Centers

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington, United States

  • Mayo Clinic Michigan, Rochester, United States

  • Houston Methodist Hospital, Houston, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • Alpha-fetoprotein

  • Circulating DNA

Drug/Treatment

  • Alfa-fetoprotein

Outcome

  • N/A

Study Design

  • Feasibility

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved